Inhaled iloprost induces long‐term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy

Inhaled iloprost is an established treatment for pulmonary arterial hypertension (PAH). However, the long‐term hemodynamic changes that inhaled iloprost induces are unclear. Here, we retrospectively enrolled 18 patients with PAH who received inhaled iloprost as add‐on to oral combination therapy fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Kenichiro, Adachi, Shiro, Nishiyama, Itsumure, Yoshida, Masahiro, Nakano, Yoshihisa, Murohara, Toyoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063964/
https://www.ncbi.nlm.nih.gov/pubmed/35514784
http://dx.doi.org/10.1002/pul2.12074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063964/
https://www.ncbi.nlm.nih.gov/pubmed/35514784
http://dx.doi.org/10.1002/pul2.12074

Ejemplares similares